125 related articles for article (PubMed ID: 12190309)
1. Exploring the role of bromine at C(10) of (+)-4-[2-[4-(8-chloro-3,10-dibromo- 6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11(R)-yl)-1-piperidinyl]-2- oxoethyl]-1-piperidinecarboxamide (Sch-66336): the discovery of indolocycloheptapyridine inhibitors of farnesyl protein transferase.
Taveras AG; Aki C; Chao J; Doll RJ; Lalwani T; Girijavallabhan V; Strickland CL; Windsor WT; Weber P; Hollinger F; Snow M; Patton R; Kirschmeier P; James L; Liu M; Nomeir A
J Med Chem; 2002 Aug; 45(18):3854-64. PubMed ID: 12190309
[TBL] [Abstract][Full Text] [Related]
2. (+)-4-[2-[4-(8-Chloro-3,10-dibromo-6,11-dihydro-5H-benzo[5, 6]cyclohepta[1,2-b]- pyridin-11(R)-yl)-1-piperidinyl]-2-oxo-ethyl]-1-piperidinecarboxamid e (SCH-66336): a very potent farnesyl protein transferase inhibitor as a novel antitumor agent.
Njoroge FG; Taveras AG; Kelly J; Remiszewski S; Mallams AK; Wolin R; Afonso A; Cooper AB; Rane DF; Liu YT; Wong J; Vibulbhan B; Pinto P; Deskus J; Alvarez CS; del Rosario J; Connolly M; Wang J; Desai J; Rossman RR; Bishop WR; Patton R; Wang L; Kirschmeier P; Ganguly AK
J Med Chem; 1998 Nov; 41(24):4890-902. PubMed ID: 9822558
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.
Mallams AK; Rossman RR; Doll RJ; Girijavallabhan VM; Ganguly AK; Petrin J; Wang L; Patton R; Bishop WR; Carr DM; Kirschmeier P; Catino JJ; Bryant MS; Chen KJ; Korfmacher WA; Nardo C; Wang S; Nomeir AA; Lin CC; Li Z; Chen J; Lee S; Dell J; Lipari P; Liu M
J Med Chem; 1998 Mar; 41(6):877-93. PubMed ID: 9526562
[TBL] [Abstract][Full Text] [Related]
5. Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.
Strickland CL; Weber PC; Windsor WT; Wu Z; Le HV; Albanese MM; Alvarez CS; Cesarz D; del Rosario J; Deskus J; Mallams AK; Njoroge FG; Piwinski JJ; Remiszewski S; Rossman RR; Taveras AG; Vibulbhan B; Doll RJ; Girijavallabhan VM; Ganguly AK
J Med Chem; 1999 Jun; 42(12):2125-35. PubMed ID: 10377218
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a human carcinoma cell line selected for resistance to the farnesyl transferase inhibitor 4-(2-(4-(8-chloro-3,10-dibromo-6,11-dihydro-5H-benzo-(5,6)-cyclohepta(1,2-b)-pyridin-11(R)-yl)-1-piperidinyl)-2-oxo-ethyl)-1-piperidinecarboxamide (SCH66336).
Bruzek LM; Poynter JN; Kaufmann SH; Adjei AA
Mol Pharmacol; 2005 Aug; 68(2):477-86. PubMed ID: 15901852
[TBL] [Abstract][Full Text] [Related]
7. Analogues of 1-(3,10-dibromo-8-chloro-6,11-dihydro-5H-benzo-[5,6]-cyclohepta [1,2-b]pyridin-11-yl)piperidine as inhibitors of farnesyl protein transferase.
Afonso A; Weinstein J; Kelly J; Wolin R; Rosenblum SB; Connolly M; Guzi T; James L; Carr D; Patton R; Bishop WR; Kirshmeier P; Liu M; Heimark L; Chen KJ; Nomeir AA
Bioorg Med Chem; 1999 Sep; 7(9):1845-55. PubMed ID: 10530932
[TBL] [Abstract][Full Text] [Related]
8. Analogs of 4-(3-bromo-8-methyl-10-methoxy-6,11-dihydro-5H-benzo[5,6]-cyclo hepta[1,2-b]pyridin-11-yl)-1-(4-pyridinylacetyl)piperidine N-oxide as inhibitors of farnesyl protein transferase.
Afonso A; Kelly J; Weinstein J; James L; Bishop WR
Bioorg Med Chem Lett; 1999 Jul; 9(13):1875-80. PubMed ID: 10406658
[TBL] [Abstract][Full Text] [Related]
9. Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations.
Taveras AG; Kirschmeier P; Baum CM
Curr Top Med Chem; 2003; 3(10):1103-14. PubMed ID: 12769711
[TBL] [Abstract][Full Text] [Related]
10. Trihalobenzocycloheptapyridine analogues of Sch 66336 as potent inhibitors of farnesyl protein transferase.
Njoroge FG; Vibulbhan B; Pinto P; Strickland CL; Bishop WR; Kirschmeir P; Girijavallabhan V; Ganguly AK
Bioorg Med Chem; 2003 Jan; 11(1):139-43. PubMed ID: 12467716
[TBL] [Abstract][Full Text] [Related]
11. Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities.
Taveras AG; Deskus J; Chao J; Vaccaro CJ; Njoroge FG; Vibulbhan B; Pinto P; Remiszewski S; del Rosario J; Doll RJ; Alvarez C; Lalwani T; Mallams AK; Rossman RR; Afonso A; Girijavallabhan VM; Ganguly AK; Pramanik B; Heimark L; Bishop WR; Wang L; Kirschmeier P; James L; Carr D; Liu M
J Med Chem; 1999 Jul; 42(14):2651-61. PubMed ID: 10411485
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of 5,6-dihydro-11H-benzo[5,6]-cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidine-N-cyanoguanidine derivatives as inhibitors of ras farnesyl protein transferase.
Cooper AB; Strickland CL; Wang J; Desai J; Kirschmeier P; Patton R; Bishop WR; Weber PC; Girijavallabhan V
Bioorg Med Chem Lett; 2002 Feb; 12(4):601-5. PubMed ID: 11844681
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of isomeric 3-piperidinyl and 3-pyrrolidinyl benzo[5,6]cyclohepta[1,2-b]pyridines: sulfonamido derivatives as inhibitors of Ras prenylation.
Kelly J; Wolin R; Connolly M; Afonso A; James L; Kirshmeier P; Bishop WR; McPhail AT
Bioorg Med Chem; 1998 Jun; 6(6):673-86. PubMed ID: 9681133
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Lipari P; Malkowski M; Ferrari E; Nielsen L; Prioli N; Dell J; Sinha D; Syed J; Korfmacher WA; Nomeir AA; Lin CC; Wang L; Taveras AG; Doll RJ; Njoroge FG; Mallams AK; Remiszewski S; Catino JJ; Girijavallabhan VM; Bishop WR
Cancer Res; 1998 Nov; 58(21):4947-56. PubMed ID: 9810004
[TBL] [Abstract][Full Text] [Related]
15. The farnesyl transferase inhibitor SCH 66336 induces a G(2) --> M or G(1) pause in sensitive human tumor cell lines.
Ashar HR; James L; Gray K; Carr D; McGuirk M; Maxwell E; Black S; Armstrong L; Doll RJ; Taveras AG; Bishop WR; Kirschmeier P
Exp Cell Res; 2001 Jan; 262(1):17-27. PubMed ID: 11120601
[TBL] [Abstract][Full Text] [Related]
16. New class of azaheptapyridine FPT inhibitors as potential cancer therapy agents.
Zhu HY; Desai J; Cooper AB; Wang J; Rane DF; Kirschmeier P; Strickland C; Liu M; Nomeir AA; Girijavallabhan VM
Bioorg Med Chem Lett; 2014 Feb; 24(4):1228-31. PubMed ID: 24462667
[TBL] [Abstract][Full Text] [Related]
17. Enzymatic kinetic resolution of piperidine atropisomers: synthesis of a key intermediate of the farnesyl protein transferase inhibitor, SCH66336.
Morgan B; Zaks A; Dodds DR; Liu J; Jain R; Megati S; Njoroge FG; Girijavallabhan VM
J Org Chem; 2000 Sep; 65(18):5451-9. PubMed ID: 10970281
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of piperidine farnesyltransferase inhibitors with reduced glucuronidation potential.
Tanaka R; Rubio A; Harn NK; Gernert D; Grese TA; Eishima J; Hara M; Yoda N; Ohashi R; Kuwabara T; Soga S; Akinaga S; Nara S; Kanda Y
Bioorg Med Chem; 2007 Feb; 15(3):1363-82. PubMed ID: 17127066
[TBL] [Abstract][Full Text] [Related]
19. Identification of (R)-N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide (CPI-1205), a Potent and Selective Inhibitor of Histone Methyltransferase EZH2, Suitable for Phase I Clinical Trials for B-Cell Lymphomas.
Vaswani RG; Gehling VS; Dakin LA; Cook AS; Nasveschuk CG; Duplessis M; Iyer P; Balasubramanian S; Zhao F; Good AC; Campbell R; Lee C; Cantone N; Cummings RT; Normant E; Bellon SF; Albrecht BK; Harmange JC; Trojer P; Audia JE; Zhang Y; Justin N; Chen S; Wilson JR; Gamblin SJ
J Med Chem; 2016 Nov; 59(21):9928-9941. PubMed ID: 27739677
[TBL] [Abstract][Full Text] [Related]
20. Farnesyl protein transferase inhibition: a novel approach to anti-tumor therapy. the discovery and development of SCH 66336.
Ganguly AK; Doll RJ; Girijavallabhan VM
Curr Med Chem; 2001 Oct; 8(12):1419-36. PubMed ID: 11562275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
